Real-Time News FIRE NOW SIP Calculators

Easy-to-understand Financial Insights
that build Wealth.

Suit Of Products

Explore Dzambhala Pro

Biocon's Bengaluru API Facility Gets 3 US FDA Observations; No Business Impact Expected

Sept. 21, 2024, 8:50 p.m.

Biocon Limited announced that the US Food and Drug Administration (US FDA) conducted a surveillance inspection of its Active Pharmaceutical Ingredient (API) facility in Bengaluru, Karnataka.<…

Unlock the Full Filing And Lot More

Access premium insights and stay ahead of the market with Dzambhala Pro.

BIOCON Regulatory